145 related articles for article (PubMed ID: 10594293)
1. Assessment of the ability of the topical skin protectant (TSP) to protect against contact dermatitis to urushiol (Rhus) antigen.
Vidmar DA; Iwane MK
Am J Contact Dermat; 1999 Dec; 10(4):190-7. PubMed ID: 10594293
[TBL] [Abstract][Full Text] [Related]
2. Treatment of poison ivy/oak allergic contact dermatitis with an extract of jewelweed.
Long D; Ballentine NH; Marks JG
Am J Contact Dermat; 1997 Sep; 8(3):150-3. PubMed ID: 9249283
[TBL] [Abstract][Full Text] [Related]
3. Urushiol Patch Test Using the T.R.U.E. TEST System.
Kim Y; Longenecker A; ElSohly MA; Gul W; Hage RJ; Hamann CP; Marks JG
Dermatitis; 2018; 29(3):127-131. PubMed ID: 29762206
[TBL] [Abstract][Full Text] [Related]
4. Allergic contact dermatitis caused by Lithraea molleoides and Lithraea brasiliensis: identification and characterization of the responsible allergens.
Alé SI; Ferreira F; González G; Epstein W
Am J Contact Dermat; 1997 Sep; 8(3):144-9. PubMed ID: 9249282
[TBL] [Abstract][Full Text] [Related]
5. A study of cross-reactions between mango contact allergens and urushiol.
Oka K; Saito F; Yasuhara T; Sugimoto A
Contact Dermatitis; 2004; 51(5-6):292-6. PubMed ID: 15606656
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the topical skin protectant in advanced development.
Liu DK; Wannemacher RW; Snider TH; Hayes TL
J Appl Toxicol; 1999 Dec; 19 Suppl 1():S40-5. PubMed ID: 10594900
[TBL] [Abstract][Full Text] [Related]
7. Sesquiterpene lactone mix patch testing supplemented with dandelion extract in patients with allergic contact dermatitis, atopic dermatitis and non-allergic chronic inflammatory skin diseases.
Jovanović M; Poljacki M; Mimica-Dukić N; Boza P; Vujanović Lj; Duran V; Stojanović S
Contact Dermatitis; 2004 Sep; 51(3):101-10. PubMed ID: 15479198
[TBL] [Abstract][Full Text] [Related]
8. Effects of topical skin protectant on heat exchange in humans.
Gabarée CL; Mair BS; Kolka MA; Stephenson LA
Aviat Space Environ Med; 1997 Nov; 68(11):1019-24. PubMed ID: 9383502
[TBL] [Abstract][Full Text] [Related]
9. Topical prevention of poison ivy/oak dermatitis.
Epstein WL
Arch Dermatol; 1989 Apr; 125(4):499-501. PubMed ID: 2522756
[TBL] [Abstract][Full Text] [Related]
10. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004.
Zug KA; McGinley-Smith D; Warshaw EM; Taylor JS; Rietschel RL; Maibach HI; Belsito DV; Fowler JF; Storrs FJ; DeLeo VA; Marks JG; Mathias CG; Pratt MD; Sasseville D
Arch Dermatol; 2008 Oct; 144(10):1329-36. PubMed ID: 18936397
[TBL] [Abstract][Full Text] [Related]
11. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol.
Kalish RS; Johnson KL
J Immunol; 1990 Dec; 145(11):3706-13. PubMed ID: 2147199
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of the German Contact Dermatitis Research Group (Deutsche Kontaktallergie-Gruppe, DKG).
Löffler H; Becker D; Brasch J; Geier J;
Br J Dermatol; 2005 Apr; 152(4):709-19. PubMed ID: 15840103
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies of poison oak immunity. I. In vitro reaction of human lymphocytes to urushiol.
Byers VS; Epstein WL; Castagnoli N; Baer H
J Clin Invest; 1979 Nov; 64(5):1437-48. PubMed ID: 315414
[TBL] [Abstract][Full Text] [Related]
14. [Allergic contact dermatitis to common ivy (Hedera helix L.)].
Ozdemir C; Schneider LA; Hinrichs R; Staib G; Weber L; Weiss JM; Scharffetter-Kochanek K
Hautarzt; 2003 Oct; 54(10):966-9. PubMed ID: 14513244
[TBL] [Abstract][Full Text] [Related]
15. Changing trends and allergens in the patch test standard series: a mayo clinic 5-year retrospective review, january 1, 2001, through december 31, 2005.
Davis MD; Scalf LA; Yiannias JA; Cheng JF; El-Azhary RA; Rohlinger AL; Farmer SA; Fett DD; Johnson JS; Linehan DL; Richardson DM; Schroeter AL; Connolly SM
Arch Dermatol; 2008 Jan; 144(1):67-72. PubMed ID: 18209170
[TBL] [Abstract][Full Text] [Related]
16. Induction of antigen specific hyposensitization to poison oak in sensitized adults.
Epstein WL; Byers VS; Frankart W
Arch Dermatol; 1982 Sep; 118(9):630-3. PubMed ID: 6180687
[TBL] [Abstract][Full Text] [Related]
17. The contact allergen replacement database and treatment of allergic contact dermatitis.
Kist JM; el-Azhary RA; Hentz JG; Yiannias JA
Arch Dermatol; 2004 Dec; 140(12):1448-50. PubMed ID: 15611421
[TBL] [Abstract][Full Text] [Related]
18. Increased retest reactivity by both patch and use test with methyldibromoglutaronitrile in sensitized individuals.
Jensen CD; Johansen JD; Menné T; Andersen KE
Acta Derm Venereol; 2006; 86(1):8-12. PubMed ID: 16585981
[TBL] [Abstract][Full Text] [Related]
19. Preservation of allergic contact dermatitis to poison ivy (urushiol) in late HIV disease. The implications and relevance to immunotherapy with contact allergens.
Smith KJ; Skelton HG; Nelson A; Wagner KF; Hackley BE
Dermatology; 1997; 195(2):145-9. PubMed ID: 9310722
[TBL] [Abstract][Full Text] [Related]
20. Patch test reaction on Ethiopian subjects with eczema.
Bilcha KD; Shibeshi D; Grangsjo A; Hiletework M
Int J Dermatol; 2009 Sep; 48(9):979-83. PubMed ID: 19702984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
